Open Access

[Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

  • Authors:
    • Yoshiyuki Yamaguchi
    • Yousuke Katata
    • Fuminori Sano
    • Hiroaki Tanioka
    • Makoto Okawaki
    • Masahiro Yamamura
    • Takeshi Nagasaka
  • View Affiliations

  • Published online on: November 25, 2021     https://doi.org/10.3892/mco.2021.2454
  • Article Number: 20
  • Copyright : © Yamaguchi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2022
Volume 16 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamaguchi Y, Katata Y, Sano F, Tanioka H, Okawaki M, Yamamura M and Nagasaka T: [Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study. Mol Clin Oncol 16: 20, 2022
APA
Yamaguchi, Y., Katata, Y., Sano, F., Tanioka, H., Okawaki, M., Yamamura, M., & Nagasaka, T. (2022). [Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study. Molecular and Clinical Oncology, 16, 20. https://doi.org/10.3892/mco.2021.2454
MLA
Yamaguchi, Y., Katata, Y., Sano, F., Tanioka, H., Okawaki, M., Yamamura, M., Nagasaka, T."[Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study". Molecular and Clinical Oncology 16.1 (2022): 20.
Chicago
Yamaguchi, Y., Katata, Y., Sano, F., Tanioka, H., Okawaki, M., Yamamura, M., Nagasaka, T."[Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study". Molecular and Clinical Oncology 16, no. 1 (2022): 20. https://doi.org/10.3892/mco.2021.2454